Mutant KRAS as a prognostic biomarker after hepatectomy for rectal cancer metastases: Does the primary disease site matter?

Neda Amini, Nikolaos Andreatos, Georgios Antonios Margonis, Stefan Buettner, Jaeyun Wang, Boris Galjart, Doris Wagner, Kazunari Sasaki, Anastasios Angelou, Jinger Sun, Carsten Kamphues, Andrea Beer, Daisuke Morioka, Inger Marie Løes, Efstathios Antoniou, Katsunori Imai, Emmanouil Pikoulis, Jin He, Klaus Kaczirek, George PoultsidesCornelis Verhoef, Per Eystein Lønning, Itaru Endo, Hideo Baba, Peter Kornprat, Federico NAucejo, Martin E. Kreis, Wolfgang L. Christopher, Matthew J. Weiss, Bashar Safar, Richard Andrew Burkhart

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Mutant KRAS as a prognostic biomarker after hepatectomy for rectal cancer metastases: Does the primary disease site matter?'. Together they form a unique fingerprint.

Medicine & Life Sciences